Predictive value of integrated 18F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer

Yukihiro Umeda; Miwa Morikawa; Masaki Anzai; Shingo Ameshima; Maiko Kadowaki; Yuko Waseda; Hiroko Shigemi; Tetsuya Tsujikawa; Yasushi Kiyono; Hidehiko Okazawa; Tamotsu Ishizuka

doi:10.1136/jitc-2019-000349

Article info

PDF

XML

Immunotherapy biomarkers

Original research

Predictive value of integrated ¹⁸F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer

Authors

Yukihiro Umeda Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Miwa Morikawa Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Masaki Anzai Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Shingo Ameshima Department of Internal Medicine, Sakai Municipal Mikuni Hospital, Fukui, Japan PubMed articles Google scholar articles
Maiko Kadowaki Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Yuko Waseda Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Hiroko Shigemi Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Tetsuya Tsujikawa Biomedical Imaging Research Center, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Yasushi Kiyono Biomedical Imaging Research Center, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Hidehiko Okazawa Biomedical Imaging Research Center, University of Fukui, Fukui, Japan PubMed articles Google scholar articles
Tamotsu Ishizuka Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan PubMed articles Google scholar articles

Citation

Umeda Y, Morikawa M, Anzai M, et al

Predictive value of integrated ¹⁸F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer

Journal for ImmunoTherapy of Cancer 2020;8:e000349. doi: 10.1136/jitc-2019-000349

Online issue publication

January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password